loadpatents
Patent applications and USPTO patent grants for Senter; Peter D..The latest application filed is for "psma antibody-drug conjugates".
Patent | Date |
---|---|
Psma Antibody-drug Conjugates App 20210023094 - Ma; Dangshe ;   et al. | 2021-01-28 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20200347149 - DORONINA; Svetlana O. ;   et al. | 2020-11-05 |
Monomethylvaline compounds capable of conjugation to ligands Grant 10,808,039 - Doronina , et al. October 20, 2 | 2020-10-20 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20190338045 - DORONINA; Svetlana O. ;   et al. | 2019-11-07 |
Monomethylvaline compounds capable of conjugation to ligands Grant 10,414,826 - Doronina , et al. Sept | 2019-09-17 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20180127512 - DORONINA; Svetlana O. ;   et al. | 2018-05-10 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20170000897 - Doronina; Svetlana O. ;   et al. | 2017-01-05 |
Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminus Grant 9,522,194 - Doronina , et al. December 20, 2 | 2016-12-20 |
Methods Of Using Monomethylvaline Compositions Having Phenylalanine Carboxy Modifications At The C-terminus App 20150044238 - Doronina; Svetlana O ;   et al. | 2015-02-12 |
Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease Grant 8,906,376 - Senter , et al. December 9, 2 | 2014-12-09 |
Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus Grant 8,871,720 - Doronina , et al. October 28, 2 | 2014-10-28 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20140220047 - Doronina; Svetlana O. ;   et al. | 2014-08-07 |
Monomethylvaline compounds capable of conjugation to ligands Grant 8,703,714 - Doronina , et al. April 22, 2 | 2014-04-22 |
Monomethylvaline compounds capable of conjugation to ligands Grant 8,557,780 - Doronina , et al. October 15, 2 | 2013-10-15 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120148608 - Doronina; Svetlana O. ;   et al. | 2012-06-14 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120148610 - Doronina; Svetlana O. ;   et al. | 2012-06-14 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120141510 - Doronina; Svetlana O. ;   et al. | 2012-06-07 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120141509 - Doronina; Svetlana O. ;   et al. | 2012-06-07 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120141508 - Doronina; Svetlana O. ;   et al. | 2012-06-07 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120034247 - Doronina; Svetlana O. ;   et al. | 2012-02-09 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120034246 - DORONINA; SVETLANA O. ;   et al. | 2012-02-09 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120027783 - DORONINA; SVETLANA O. ;   et al. | 2012-02-02 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120027784 - Doronina; Svetlana O. ;   et al. | 2012-02-02 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120003247 - Doronina; Svetlana O. ;   et al. | 2012-01-05 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120003248 - Doronina; Svetlana O. ;   et al. | 2012-01-05 |
Toxin Conjugated Eph Receptor Antibodies App 20110280892 - Kinch; Michael S. ;   et al. | 2011-11-17 |
Monomethylvaline compounds capable of conjugation to ligands Grant 7,994,135 - Doronina , et al. August 9, 2 | 2011-08-09 |
Monomethylvaline compounds capable of conjugation to ligands Grant 7,964,566 - Doronina , et al. June 21, 2 | 2011-06-21 |
Monomethylvaline compounds capable of conjugation to ligands Grant 7,964,567 - Doronina , et al. June 21, 2 | 2011-06-21 |
Drug Conjugates And Their Use For Treating Cancer, An Autoimmune Disease Or An Infectious Disease App 20110064753 - Senter; Peter D. ;   et al. | 2011-03-17 |
Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease Grant 7,851,437 - Senter , et al. December 14, 2 | 2010-12-14 |
Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease Grant 7,829,531 - Senter , et al. November 9, 2 | 2010-11-09 |
Monomethylvaline compounds capable of conjugation to ligands Grant 7,745,394 - Doronina , et al. June 29, 2 | 2010-06-29 |
Drug Conjugates And Their Use For Treating Cancer, An Autoimmune Disease Or An Infectious Disease App 20100062008 - Senter; Peter D. ;   et al. | 2010-03-11 |
Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease Grant 7,659,241 - Senter , et al. February 9, 2 | 2010-02-09 |
Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease App 20090324621 - Senter; Peter D. ;   et al. | 2009-12-31 |
p-amidobenzylethers in drug delivery agents Grant 7,553,816 - Senter , et al. June 30, 2 | 2009-06-30 |
Monomethylvaline Compounds Having Phenylalanine Carboxy Modifications at the C-Terminus App 20090111756 - Doronina; Svetlana O. ;   et al. | 2009-04-30 |
Monomethylvaline compounds capable of conjugation to ligands Grant 7,498,298 - Doronina , et al. March 3, 2 | 2009-03-03 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20090047296 - Doronina; Svetlana O. ;   et al. | 2009-02-19 |
Recombinant Anti-cd30 Antibodies And Uses Thereof App 20080317747 - Francisco; Joseph A. ;   et al. | 2008-12-25 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20080248051 - Doronina; Svetlana O. ;   et al. | 2008-10-09 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20080248053 - Doronina; Svetlana O. ;   et al. | 2008-10-09 |
Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20080226657 - Doronina; Svetlana O. ;   et al. | 2008-09-18 |
Pentapeptide compounds and uses related thereto Grant 7,423,116 - Doronina , et al. September 9, 2 | 2008-09-09 |
Recombinant Anti-cd30 Antibodies And Uses Thereof App 20080213289 - Francisco; Joseph A. ;   et al. | 2008-09-04 |
Recombinant Anti-Cd30 Antibodies and Uses Thereof App 20070258987 - Francisco; Joseph A. ;   et al. | 2007-11-08 |
Pentapeptide compounds and uses related thereto Grant 7,256,257 - Doronina , et al. August 14, 2 | 2007-08-14 |
PSMA antibody-drug conjugates App 20070160617 - Ma; Dangshe ;   et al. | 2007-07-12 |
Pentapeptide compounds and uses related thereto App 20060229253 - Doronina; Svetlana ;   et al. | 2006-10-12 |
Pentapeptide compounds and uses related thereto Grant 7,098,308 - Senter , et al. August 29, 2 | 2006-08-29 |
p-Amidobenzylethers in drug delivery agents Grant 7,091,186 - Senter , et al. August 15, 2 | 2006-08-15 |
Monomethylvaline compounds capable of conjugation to ligands App 20050238649 - Doronina, Svetlana O. ;   et al. | 2005-10-27 |
Melphalan prodrugs App 20050214310 - Toki, Brian E. ;   et al. | 2005-09-29 |
Anti-CD20 antibody-drug conjugates for the treatment of cancer and immune disorders App 20050180972 - Wahl, Alan F. ;   et al. | 2005-08-18 |
Pentapeptide compounds and uses related thereto App 20050113308 - Senter, Peter D. ;   et al. | 2005-05-26 |
Pentapeptide compounds and uses related thereto Grant 6,884,869 - Senter , et al. April 26, 2 | 2005-04-26 |
Pentapeptide Compounds And Uses Related Thereto App 20050009751 - Senter, Peter D. ;   et al. | 2005-01-13 |
Pentapeptide compounds and uses related thereto App 20040157782 - Doronina, Svetlana ;   et al. | 2004-08-12 |
Bioconjugates and uses thereof App 20040115207 - Irwin, Bernstein D ;   et al. | 2004-06-17 |
Recombinant anti-CD30 antibodies and uses thereof App 20040018194 - Francisco, Joseph A. ;   et al. | 2004-01-29 |
P-amidobenzylethers in drug delivery agents App 20030130189 - Senter, Peter D. ;   et al. | 2003-07-10 |
p-Amidobenzylethers in drug delivery agents App 20030096743 - Senter, Peter D. ;   et al. | 2003-05-22 |
Recombinant antibody-enzyme fusion proteins Grant 6,132,722 - Siemers , et al. October 17, 2 | 2000-10-17 |
Prodrugs for .beta.-lactamase and uses thereof Grant 5,773,435 - Kadow , et al. June 30, 1 | 1998-06-30 |
Epipodophyllotoxin glucoside 4'-phosphate derivatives Grant RE35,524 - Saulnier , et al. June 3, 1 | 1997-06-03 |
Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells Grant 4,975,278 - Senter , et al. December 4, 1 | 1990-12-04 |
Drug-monoclonal antibody conjugates Grant 4,952,394 - Senter August 28, 1 | 1990-08-28 |
Gelonin immunotoxin Grant 4,888,415 - Lambert , et al. December 19, 1 | 1989-12-19 |
Mitomycin phosphate derivatives Grant 4,874,779 - Senter October 17, 1 | 1989-10-17 |
Cell-delivery agent Grant 4,625,014 - Senter , et al. November 25, 1 | 1986-11-25 |
Acid-cleavable compound Grant 4,618,492 - Blattler , et al. October 21, 1 | 1986-10-21 |
Acid-cleavable compound, use in protein conjugates and drug delivery systems Grant 4,569,789 - Blattler , et al. February 11, 1 | 1986-02-11 |
Acid-cleavable compound Grant 4,542,225 - Blattler , et al. September 17, 1 | 1985-09-17 |
NCAGE Code | 4QUW7 | SENTER, PETER D |
CAGE Code | 4QUW7 | SENTER, PETER D |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.